To require that the retail list price for certain prescription drugs and biological products may not exceed the average retail list price for the drug or biological product among certain nations.
About This Bill
Committee
Latest Action · April 19, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.